BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11489002)

  • 1. Gemcitabine in the treatment of ovarian cancer.
    Hansen SW
    Int J Gynecol Cancer; 2001; 11 Suppl 1():39-41. PubMed ID: 11489002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine in the treatment of ovarian cancer.
    Hansen SW; Tuxen MK; Sessa C
    Ann Oncol; 1999; 10 Suppl 1():51-3. PubMed ID: 10219453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma.
    Hansen SW
    Semin Oncol; 2002 Feb; 29(1 Suppl 1):17-9. PubMed ID: 11840416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gemcitabine-based doublets in the management of ovarian carcinoma.
    Thigpen T
    Semin Oncol; 2002 Feb; 29(1 Suppl 1):11-6. PubMed ID: 11840415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in the chemotherapy of ovarian cancer.
    Ozols RF
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-86-S15-90. PubMed ID: 9346230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gemcitabine in the treatment of ovarian cancer.
    Ozols RF
    Semin Oncol; 2000 Feb; 27(1 Suppl 2):40-7. PubMed ID: 10697035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine in ovarian cancer.
    Orlando M; Mandachain M
    Semin Oncol; 2001 Jun; 28(3 Suppl 10):62-9. PubMed ID: 11510036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.
    Wang F; Du X; Li X; Liu N; Yu H; Sheng X
    Medicine (Baltimore); 2016 Dec; 95(51):e5696. PubMed ID: 28002342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine in ovarian cancer: an overview of safety and efficacy.
    Kaufmann M; von Minckwitz G
    Eur J Cancer; 1997 Jan; 33 Suppl 1():S31-3. PubMed ID: 9166098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of gemcitabine in first-line treatment of advanced ovarian carcinoma.
    Thigpen T
    Semin Oncol; 2006 Apr; 33(2 Suppl 6):S26-32. PubMed ID: 16716800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine in non-small cell lung cancer.
    Crinò L; Cappuzzo F
    Expert Opin Pharmacother; 2002 Jun; 3(6):745-53. PubMed ID: 12036414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gemcitabine in the treatment of malignant mesothelioma.
    Kindler HL; van Meerbeeck JP
    Semin Oncol; 2002 Feb; 29(1):70-6. PubMed ID: 11836671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future perspectives in advanced bladder cancer: is there a new standard?
    von der Maase H
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer.
    Bunn PA
    Semin Oncol; 1999 Feb; 26(1 Suppl 4):25-30. PubMed ID: 10201518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triplet combination of gemcitabine, carboplatin, and paclitaxel in previously treated, relapsed ovarian and peritoneal carcinoma: an experience in Taiwan.
    Liu FS; Ho ES; Hung MJ; Hwang SF; Lu CH; Ke YM
    Gynecol Oncol; 2004 Aug; 94(2):393-7. PubMed ID: 15297178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine combination chemotherapy of ovarian cancer.
    Mutch DG
    Gynecol Oncol; 2003 Aug; 90(2 Pt 2):S16-20. PubMed ID: 12928001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.
    Harper P
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):2-12. PubMed ID: 12917815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study.
    Papadimitriou CA; Fountzilas G; Aravantinos G; Kalofonos C; Moulopoulos LA; Briassoulis E; Gika D; Dimopoulos MA;
    Gynecol Oncol; 2004 Jan; 92(1):152-9. PubMed ID: 14751151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer.
    Friedlander M; Millward MJ; Bell D; Bugat R; Harnett P; Moreno JA; Campbell L; Varette C; Ripoche V; Kayitalire L
    Ann Oncol; 1998 Dec; 9(12):1343-5. PubMed ID: 9932166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.